The clinical pharmacokinetics of N-5-dimethyl-9-[(2-methoxy-4-methyl-sulfonylamino)phenylamino]-4 -acridinecarboxamide (CI-921) in a phase 1 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples